XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders’ Equity and Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended
Feb. 15, 2022
Mar. 23, 2021
Jan. 25, 2021
Jan. 12, 2021
Oct. 31, 2021
Sep. 30, 2021
Jun. 30, 2022
Jan. 31, 2021
Jun. 30, 2022
Aug. 31, 2020
Class of Stock [Line Items]                    
Number of shares issued (in shares)     38,300 33,400   2,300   27,000    
Average share price (in dollars per share)     $ 6.00 $ 3.05   $ 6.15        
Net proceeds     $ 229.6 $ 101.5   $ 13.9   $ 38.0    
Authorized amount of stock to be issued                   $ 125.0
Offering costs           $ 0.6        
Weighted-average grant date fair value (in dollars per share)             $ 1.17   $ 1.33  
Granted (in shares)                 12,797  
Granted (in dollars per share)                 $ 2.11  
Common Stock                    
Class of Stock [Line Items]                    
Authorized amount of stock to be issued                   $ 40.0
Executive Officer                    
Class of Stock [Line Items]                    
Granted (in shares) 4,300                  
Granted (in dollars per share) $ 2.18                  
Restricted Stock                    
Class of Stock [Line Items]                    
Vesting period                 2 years 3 months 18 days  
Restricted Stock | Vesting on October 18, 2022                    
Class of Stock [Line Items]                    
Vesting percentage         33.00%          
Restricted Stock | Vesting every three months following October 18, 2022                    
Class of Stock [Line Items]                    
Vesting percentage         8.00%          
Restricted Stock | BioDiscovery                    
Class of Stock [Line Items]                    
Units granted (in shares)         5,000          
Granted (in dollars per share)         $ 5.20          
RSUs                    
Class of Stock [Line Items]                    
Units granted (in shares)                 0  
Granted (in dollars per share)                 $ 0  
Total intrinsic value                 $ 0.6  
Weighted average remaining contractual term                 10 months 24 days  
Option | Executive Officer                    
Class of Stock [Line Items]                    
Vesting period 48 months                  
PSUs                    
Class of Stock [Line Items]                    
Units granted (in shares)                 0  
Granted (in dollars per share)                 $ 0  
Weighted average remaining contractual term                 2 years 10 months 24 days  
Cowen                    
Class of Stock [Line Items]                    
Aggregate offering price   $ 350.0                
Commission fee   3.00%